Azelis: Transparency Notifications From UBS Group AG

ANTWERP, Belgium--( BUSINESS WIRE)--REGULATED INFORMATION

In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 29 May 2026 and 1 June 2026, it has received 2 transparency notifications from UBS Group AG.

1. Summary of the notifications

UBS Group AG reported in its notification dated 29 May 2026, that on 27 May 2026, following an acquisition of shares with voting securities and equivalent financial instruments, UBS Group AG (taking into account the holding of all its affiliates), increased its holdings and crossed the threshold of 3.00% in Azelis Group NV.

On 27 May 2026, UBS Group AG (taking into account the holding of all its affiliates) owned 595,082 shares with voting rights, representing 0.24% of the total number of shares issued by the company (243,921,719), as well as 7,261,140 equivalent financial instruments, representing 2.98% of the voting rights issued by the company.

UBS Group AG reported in its notification dated 1 June 2026, that on 28 May 2026, following an acquisition of equivalent financial instruments, UBS Group AG (taking into account the holding of all its affiliates), increased its holdings in equivalent financial instruments and crossed the threshold of 3.00% in Azelis Group NV.

On 28 May 2026, UBS Group AG (taking into account the holding of all its affiliates) owned 807,166 shares with voting rights, representing 0.33% of the total number of shares issued by the company (243,921,719), versus 595,082 shares representing 0.24% in its previous notification dated 29 May 2026, as well as 7,522,357 equivalent financial instruments, representing 3.08% of the voting rights issued by the company, versus 7,261,140 equivalent financial instruments, representing 2.98% in its previous notification dated 29 May 2026.

2. Content of the notifications

Reason for the notifications

Acquisition of voting securities or voting rights

Notification by

A parent undertaking or a controlling person

Persons subject to the notification requirement

Name

Address (for legal entities)

UBS Group AG

Bahnhofstrasse 45, 8001 Zürich

Date on which the threshold is crossed

27 May 2026 and 28 May 2026

Threshold that is crossed (in %)

Denominator

243,921,719

Notified Details

Transparency declaration dated 29 May 2026

A) Voting rights

Previous notification

After the transaction

# of voting rights

% of voting rights

Holders of voting rights

Linked to securities

Not linked to the securities

Linked to securities

Not linked to the securities

UBS Group AG

0.00%

UBS AG

160,237

0.07%

UBS Asset Management (Europe) S.A.

96,614

0.04%

UBS Asset Management Life Limited

8,128

0.00%

UBS Fund Management (Switzerland) AG

280,102

0.11%

UBS Securities LLC

50,000

0.02%

UBS Switzerland AG

0.00%

Subtotal

595,082

0.24%

TOTAL

595,082

0.24%

B) Equivalent financial instruments

After the transaction

Holders of equivalent

financial instruments

Type of financial instrument

Expiration date

Exercise period or date

# of voting rights that may be acquired if the instrument is exercised

% of voting rights

Settlement

UBS AG

Long Call Option

17/12/2027

177,000

0.07%

physical

UBS AG

Long Call Option

17/03/2028

61,500

0.03%

physical

UBS AG

Equity Swaps

28/03/2028

383

0.00%

cash

UBS Switzerland AG

Right of use over shares

At any time

4,878,428

2.00%

physical

UBS AG

Right of use over shares

At any time

1,162,392

0.48%

physical

UBS Switzerland AG

Right to Recall of Lent shares

At any time

384,543

0.16%

physical

UBS AG

Right to Recall of Lent shares

At any time

596,894

0.24%

physical

TOTAL

7,261,140

2.98%

TOTAL (A & B)

# of voting rights

% of voting rights

CALCULATE

7,856,222

3.22%

Transparency declaration dated 1 June 2026

A) Voting rights

Previous notification

After the transaction

# of voting rights

% of voting rights

Holders of voting rights

Linked to securities

Not linked to the securities

Linked to securities

Not linked to the securities

UBS Group AG

0.00%

UBS AG

160,237

372,322

0.15%

UBS Asset Management (Europe) S.A.

96,614

0.04%

UBS Asset Management Life Limited

8,128

0.00%

UBS Fund Management (Switzerland) AG

280,102

0.11%

UBS Securities LLC

50,000

0.02%

UBS Switzerland AG

0.00%

Subtotal

595,082

807,166

0.33%

TOTAL

807,166

0.33%

B) Equivalent financial instruments

After the transaction

Holders of equivalent

financial instruments

Type of financial instrument

Expiration date

Exercise period or date

# of voting rights that may be acquired if the instrument is exercised

% of voting rights

Settlement

UBS AG

Long Call Option

17/12/2027

177,000

0.07%

physical

UBS AG

Long Call Option

17/03/2028

61,500

0.03%

physical

UBS AG

Equity Swaps

28/03/2028

297

0.00%

cash

UBS Switzerland AG

Right of use over shares

At any time

5,225,719

2.14%

physical

UBS AG

Right of use over shares

At any time

1,313,007

0.54%

physical

UBS Switzerland AG

Right to Recall of Lent shares

At any time

94,243

0.04%

physical

UBS AG

Right to Recall of Lent shares

At any time

596,894

0.24%

physical

UBS AG

Substitution Right

At any time

53,697

0.02%

physical

TOTAL

7,522,357

3.08%

TOTAL (A & B)

# of voting rights

% of voting rights

CALCULATE

8,329,523

3.41%

Chain of controlled undertakings through which the holding is effectively held, if applicable

Please see full chain of control attached.

Additional information

The disclosure obligation arose due to the indirect holdings in financial instrument of UBS Group AG in voting rights of Azelis Group NV, held directly by controlled undertakings, going above 3% on 27th May 2026.

3. Further information

The full transparency notifications as well as this press release can be consulted on the Azelis Group NV’s website.

··················· END ···················

About Azelis

Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry, present in 64 countries across the globe with over 4,100 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a comprehensive portfolio of complementary products to more than 65,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.1 billion (2025). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.

Across our extensive network of more than 70 application laboratories, our award-winning teams develop innovative and sustainable formulations and provide technical guidance throughout the product development process. We combine global market reach with a local footprint to offer reliable, integrated, and unique digital services to local customers and attractive business opportunities to principals. Recognised for our sustainability leadership, we are committed to responsible growth that positively impacts people, communities and the planet. Through the application of science and deep market expertise, we act as catalysts for innovation, enabling our customers to win and our principals to grow.

Innovation through formulation.

www.azelis.com

Attachment – Chain of control

11. Information in relation to the person subject to the notification obligation – organizational

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management (Europe) S.A.

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management Holding (No. 2) Ltd

UBS Asset Management Holding Ltd

UBS Asset Management Life Ltd

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management Switzerland AG

UBS Fund Management (Switzerland) AG

UBS Group AG

UBS AG

UBS Americas Holding LLC

UBS Americas Inc.

UBS Securities LLC

UBS Group AG

UBS AG

UBS Switzerland AG